BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 11792835)

  • 1. Grafts of supplementary thymuses injected with allogeneic pancreatic islets protect nonobese diabetic mice against diabetes.
    Salaün J; Simmenauer N; Belo P; Coutinho A; Le Douarin NM
    Proc Natl Acad Sci U S A; 2002 Jan; 99(2):874-7. PubMed ID: 11792835
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Regulatory phenomena in tolerance induction].
    Salaün J
    J Soc Biol; 2002; 196(4):259-61. PubMed ID: 12645291
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevention of overt diabetes and insulitis by intrathymic injection of syngeneic islets in newborn nonobese diabetic (NOD) mice.
    Nomura Y; Stein E; Mullen Y
    Transplantation; 1993 Sep; 56(3):638-42. PubMed ID: 8212162
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Thymic development of autoreactive T cells in NOD mice is regulated in an age-dependent manner.
    He Q; Morillon YM; Spidale NA; Kroger CJ; Liu B; Sartor RB; Wang B; Tisch R
    J Immunol; 2013 Dec; 191(12):5858-66. PubMed ID: 24198282
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Induction of insulitis in athymic (nude) mice. The effect of NOD thymus and pancreas transplantation.
    Georgiou HM; Mandel TE
    Diabetes; 1995 Jan; 44(1):49-59. PubMed ID: 7813814
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intrathymic islet cell transplantation reduces beta-cell autoimmunity and prevents diabetes in NOD/Lt mice.
    Gerling IC; Serreze DV; Christianson SW; Leiter EH
    Diabetes; 1992 Dec; 41(12):1672-6. PubMed ID: 1446808
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Abnormal T cell selection on nod thymic epithelium is sufficient to induce autoimmune manifestations in C57BL/6 athymic nude mice.
    Thomas-Vaslin V; Damotte D; Coltey M; Le Douarin NM; Coutinho A; Salaün J
    Proc Natl Acad Sci U S A; 1997 Apr; 94(9):4598-603. PubMed ID: 9114036
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Major histocompatibility complex class I-restricted infiltration and destruction of pancreatic islets by NOD mouse-derived beta-cell cytotoxic CD8+ T-cell clones in vivo.
    Utsugi T; Yoon JW; Park BJ; Imamura M; Averill N; Kawazu S; Santamaria P
    Diabetes; 1996 Aug; 45(8):1121-31. PubMed ID: 8690161
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Analyses of development of insulitogenic T lymphocytes in NOD mice by transplantation of bone marrow, thymus, and pancreas.
    Ida T; Yasumizu R; Ohnishi Y; Honxue F; Oyaizu N; Than S; Sugiura K; Inaba MM; Kuzuya H; Makino S
    Transplantation; 1990 May; 49(5):976-82. PubMed ID: 2186525
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Recurrent autoimmunity accelerates destruction of minor and major histoincompatible islet grafts in nonobese diabetic (NOD) mice.
    Okitsu T; Bartlett ST; Hadley GA; Drachenberg CB; Farney AC
    Am J Transplant; 2001 Jul; 1(2):138-45. PubMed ID: 12099361
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Triptolide ameliorates autoimmune diabetes and prolongs islet graft survival in nonobese diabetic mice.
    Huang SH; Lin GJ; Chu CH; Yu JC; Chen TW; Chen YW; Chien MW; Chu CC; Sytwu HK
    Pancreas; 2013 Apr; 42(3):442-51. PubMed ID: 23146919
    [TBL] [Abstract][Full Text] [Related]  

  • 12. More stringent conditions of plasmid DNA vaccination are required to protect grafted versus endogenous islets in nonobese diabetic mice.
    Seifarth C; Pop S; Liu B; Wong CP; Tisch R
    J Immunol; 2003 Jul; 171(1):469-76. PubMed ID: 12817032
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Depleting anti-CD4 monoclonal antibody cures new-onset diabetes, prevents recurrent autoimmune diabetes, and delays allograft rejection in nonobese diabetic mice.
    Makhlouf L; Grey ST; Dong V; Csizmadia E; Arvelo MB; Auchincloss H; Ferran C; Sayegh MH
    Transplantation; 2004 Apr; 77(7):990-7. PubMed ID: 15087759
    [TBL] [Abstract][Full Text] [Related]  

  • 14. BCG immunotherapy prevents recurrence of diabetes in islet grafts transplanted into spontaneously diabetic NOD mice.
    Lakey JR; Singh B; Warnock GL; Rajotte RV
    Transplantation; 1994 Apr; 57(8):1213-7. PubMed ID: 8178349
    [TBL] [Abstract][Full Text] [Related]  

  • 15. NOD fetal thymus organ culture: an in vitro model for the development of T cells involved in IDDM.
    Wilson SS; DeLuca D
    J Autoimmun; 1997 Oct; 10(5):461-72. PubMed ID: 9376074
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Early autoimmune destruction of islet grafts is associated with a restricted repertoire of IGRP-specific CD8+ T cells in diabetic nonobese diabetic mice.
    Wong CP; Li L; Frelinger JA; Tisch R
    J Immunol; 2006 Feb; 176(3):1637-44. PubMed ID: 16424193
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vitro xenorecognition of adult pig pancreatic islet cells by splenocytes from nonobese diabetic or non-diabetes-prone mice.
    Rivereau AS; You S; Lalain S; Gouin E; Saï P
    Transplantation; 1998 Sep; 66(5):633-8. PubMed ID: 9753345
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Allogeneic chimerism induces donor-specific tolerance to simultaneous islet allografts in nonobese diabetic mice.
    Li H; Kaufman CL; Ildstad ST
    Surgery; 1995 Aug; 118(2):192-7; discussion 197-8. PubMed ID: 7638733
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development of diabetogenic T cells from NOD/Lt marrow is blocked when an allo-H-2 haplotype is expressed on cells of hemopoietic origin, but not on thymic epithelium.
    Serreze DV; Leiter EH
    J Immunol; 1991 Aug; 147(4):1222-9. PubMed ID: 1869820
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prevention of recurrent diabetes in syngenic islet-transplanted NOD mice by transfusion of autoreactive T lymphocytes.
    Utsugi T; Nagata M; Kawamura T; Yoon JW
    Transplantation; 1994 Jun; 57(12):1799-804. PubMed ID: 7912459
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.